Proud to be presenting our abstract 4716 An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL) at ASH 2019 between 6 and 8 PM tonight in Orlando.
ASH 2019: Proud to be presenting our abstract... - CLL Support
ASH 2019
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
5 Replies
•
Good work, Brian!
We are proud of you, too!
Our CLL specialist is at this conference as well.
Thanks for your dedication and hard work!!!
Thank you!!!!
Not what you're looking for?
You may also like...
ASH 2019
Hi,
Off to ASH soon with about 20 interviews with top researchers already scheduled, scores of oral...
ASH 2019
The 2019 ASH meeting is approximately two months away. Is there any exciting news anticipated at...
Reporting from ASCO 2019 (yes ASCO, not ASH)
Hi,
With ASH looming, it’s about time I finish up my reporting from ASCO 2019, the other huge...
ASH 2019: U-MRD by subgroup (ibrutinib+venetoclax) CAPTIVATE trial
This is how we achieve personalized, precision medicine.
73% of patients achieved U-MRD4 in BM...
ASH 2019 CLL highlights and 'hot' topics - Drs Nicole Lamanna & Florence Cymbalista
Prof Nicole Lamanna - ASH 2019 - Maturing CLL clinical trial data
Dr. Nicole Lamanna, Associate...
ASH 2012 Ibrutinib Press Conference
